Poland · Delayed Price · Currency is PLN Massmedica Statistics
Total Valuation
Massmedica has a market cap or net worth of PLN 10.63 million. The enterprise value is 19.20 million.
| Market Cap | 10.63M |
| Enterprise Value | 19.20M |
Important Dates
The next confirmed earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Massmedica has 2.41 million shares outstanding.
| Current Share Class | 2.41M |
| Shares Outstanding | 2.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 72.86% |
| Owned by Institutions (%) | n/a |
| Float | 422,345 |
Valuation Ratios
The trailing PE ratio is 15.64.
| PE Ratio | 15.64 |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| PB Ratio | 1.72 |
| P/TBV Ratio | 1.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 122.76 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 28.26 |
| EV / Sales | 0.60 |
| EV / EBITDA | 8.31 |
| EV / EBIT | 10.36 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.28, with a Debt / Equity ratio of 1.47.
| Current Ratio | 1.28 |
| Quick Ratio | 0.53 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | 3.94 |
| Debt / FCF | -12.68 |
| Interest Coverage | 3.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.45% |
| Return on Capital Employed (ROCE) | 22.62% |
| Weighted Average Cost of Capital (WACC) | 5.33% |
| Revenue Per Employee | 2.28M |
| Profits Per Employee | 48,523 |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Massmedica has paid 361,154 in taxes.
| Income Tax | 361,154 |
| Effective Tax Rate | 34.71% |
Stock Price Statistics
The stock price has increased by +6.28% in the last 52 weeks. The beta is 0.37, so Massmedica's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +6.28% |
| 50-Day Moving Average | 4.32 |
| 200-Day Moving Average | 4.31 |
| Relative Strength Index (RSI) | 52.83 |
| Average Volume (20 Days) | 509 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Massmedica had revenue of PLN 31.94 million and earned 679,319 in profits. Earnings per share was 0.28.
| Revenue | 31.94M |
| Gross Profit | 13.33M |
| Operating Income | 1.85M |
| Pretax Income | 1.04M |
| Net Income | 679,319 |
| EBITDA | 2.31M |
| EBIT | 1.85M |
| Earnings Per Share (EPS) | 0.28 |
Balance Sheet
The company has 525,114 in cash and 9.10 million in debt, with a net cash position of -8.57 million or -3.55 per share.
| Cash & Cash Equivalents | 525,114 |
| Total Debt | 9.10M |
| Net Cash | -8.57M |
| Net Cash Per Share | -3.55 |
| Equity (Book Value) | 6.19M |
| Book Value Per Share | 2.56 |
| Working Capital | 5.07M |
Cash Flow
In the last 12 months, operating cash flow was 86,554 and capital expenditures -804,379, giving a free cash flow of -717,825.
| Operating Cash Flow | 86,554 |
| Capital Expenditures | -804,379 |
| Depreciation & Amortization | 457,929 |
| Net Borrowing | 1.07M |
| Free Cash Flow | -717,825 |
| FCF Per Share | -0.30 |
Margins
Gross margin is 41.74%, with operating and profit margins of 5.80% and 2.13%.
| Gross Margin | 41.74% |
| Operating Margin | 5.80% |
| Pretax Margin | 3.26% |
| Profit Margin | 2.13% |
| EBITDA Margin | 7.23% |
| EBIT Margin | 5.80% |
| FCF Margin | n/a |
Dividends & Yields
Massmedica does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.80% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 6.39% |
| FCF Yield | -6.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Massmedica has an Altman Z-Score of 2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2 |
| Piotroski F-Score | 3 |